Sumitomo Mitsui Trust Group
DGX icon

Sumitomo Mitsui Trust Group’s Quest Diagnostics DGX Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$51.9M Sell
264,754
-12,429
-4% -$2.41M 0.03% 431
2025
Q4 		$48.1M Sell
277,183
-1,469
-0.5% -$267K 0.03% 478
2025
Q3 		$53.1M Buy
278,652
+3,549
+1% +$630K 0.03% 455
2025
Q2 		$49.4M Sell
275,103
-3,077
-1% -$534K 0.03% 457
2025
Q1 		$47.1M Buy
278,180
+1,207
+0.4% +$198K 0.03% 455
2024
Q4 		$41.8M Sell
276,973
-8,149
-3% -$1.27M 0.03% 499
2024
Q3 		$44.3M Sell
285,122
-4,223
-1% -$631K 0.03% 474
2024
Q2 		$39.6M Sell
289,345
-10,251
-3% -$1.4M 0.03% 488
2024
Q1 		$39.9M Sell
299,596
-6,832
-2% -$886K 0.03% 559
2023
Q4 		$42.3M Sell
306,428
-2,297
-0.7% -$302K 0.03% 520
2023
Q3 		$37.6M Sell
308,725
-1,213
-0.4% -$162K 0.03% 537
2023
Q2 		$43.6M Sell
309,938
-44,132
-12% -$6.08M 0.03% 514
2023
Q1 		$50.1M Sell
354,070
-126,375
-26% -$18.1M 0.04% 495
2022
Q4 		$75.2M Sell
480,445
-102,816
-18% -$14.8M 0.06% 369
2022
Q3 		$71.6M Sell
583,261
-10,838
-2% -$1.43M 0.06% 373
2022
Q2 		$79M Buy
594,099
+102,969
+21% +$14M 0.06% 363
2022
Q1 		$67.2M Sell
491,130
-155,496
-24% -$21.7M 0.04% 443
2021
Q4 		$112M Sell
646,626
-217,163
-25% -$33M 0.07% 308
2021
Q3 		$126M Sell
863,789
-26,116
-3% -$3.82M 0.08% 281
2021
Q2 		$117M Sell
889,905
-68,845
-7% -$9.01M 0.07% 312
2021
Q1 		$123M Buy
958,750
+139,256
+17% +$17.2M 0.08% 296
2020
Q4 		$97.7M Sell
819,494
-5,198
-0.6% -$634K 0.06% 346
2020
Q3 		$94.4M Sell
824,692
-142,596
-15% -$16.8M 0.06% 324
2020
Q2 		$110M Buy
967,288
+405,024
+72% +$43M 0.08% 282
2020
Q1 		$44.8M Buy
562,264
+52,516
+10% +$5.44M 0.04% 468
2019
Q4 		$54.2M Buy
509,748
+6,537
+1% +$682K 0.04% 443
2019
Q3 		$53.9M Sell
503,211
-1,620
-0.3% -$166K 0.05% 420
2019
Q2 		$51.4M Sell
504,831
-2,177
-0.4% -$209K 0.05% 426
2019
Q1 		$45.6M Buy
507,008
+2,082
+0.4% +$180K 0.04% 450
2018
Q4 		$41.4M Buy
504,926
+69,312
+16% +$6.5M 0.04% 443
2018
Q3 		$47M Buy
435,614
+7,214
+2% +$791K 0.05% 400
2018
Q2 		$47.1M Buy
428,400
+16,069
+4% +$1.67M 0.05% 382
2018
Q1 		$41.4M Sell
412,331
-21,544
-5% -$2.21M 0.05% 392
2017
Q4 		$42.7M Buy
433,875
+1,573
+0.4% +$149K 0.06% 371
2017
Q3 		$40.5M Sell
432,302
-2,968
-0.7% -$315K 0.06% 354
2017
Q2 		$48.4M Buy
435,270
+10,293
+2% +$1.09M 0.07% 307
2017
Q1 		$41.7M Buy
424,977
+13,921
+3% +$1.33M 0.06% 331
2016
Q4 		$37.8M Sell
411,056
-3,334
-0.8% -$287K 0.06% 346
2016
Q3 		$35.1M Buy
414,390
+11,258
+3% +$945K 0.06% 383
2016
Q2 		$32.8M Sell
403,132
-5,086
-1% -$387K 0.06% 374
2016
Q1 		$29.2M Sell
408,218
-2,426
-0.6% -$163K 0.05% 409
2015
Q4 		$29.5M Sell
410,644
-42,487
-9% -$2.86M 0.05% 405
2015
Q3 		$27.9M Buy
453,131
+29,153
+7% +$2.04M 0.05% 408
2015
Q2 		$30.6M Sell
423,978
-3,588
-0.8% -$265K 0.05% 393
2015
Q1 		$32.9M Buy
427,566
+14,730
+4% +$1.05M 0.06% 376
2014
Q4 		$28M Buy
412,836
+48,238
+13% +$3.04M 0.05% 394
2014
Q3 		$22.1M Buy
364,598
+3,432
+1% +$211K 0.04% 454
2014
Q2 		$21.2M Sell
361,166
-83,870
-19% -$4.91M 0.04% 470
2014
Q1 		$25.8M Buy
445,036
+47,001
+12% +$2.52M 0.05% 408
2013
Q4 		$21.5M Sell
398,035
-29,770
-7% -$1.77M 0.04% 467
2013
Q3 		$26.4M Sell
427,805
-2,404
-0.6% -$144K 0.06% 388
2013
Q2 		$26.1M Buy
+430,209
New +$25.6M 0.06% 377

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Sumitomo Mitsui Trust Group's DGX Position: Q1 2026 in Review

Sumitomo Mitsui Trust Group reduced its Quest Diagnostics (DGX) stake by 4.5% in Q1 2026, selling an estimated $2.41M and leaving 264,754 shares worth $51.9M. The position accounts for 0.03% of the portfolio, ranked #431.

Sumitomo Mitsui Trust Group first reported a position in DGX in Q2 2013 and has held it in 52 quarters since. The position peaked at $126M in Q3 2021. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Sumitomo Mitsui Trust Group held 264,754 shares of Quest Diagnostics worth $51.9M as of Q1 2026.
  • Sumitomo Mitsui Trust Group sold 12,429 Quest Diagnostics shares in Q1 2026, an estimated $2.41M.
  • Quest Diagnostics made up 0.03% of Sumitomo Mitsui Trust Group's portfolio in Q1 2026, its #431 holding.
  • Sumitomo Mitsui Trust Group first reported a position in Quest Diagnostics in Q2 2013 and has held it in 52 quarters since.
  • Sumitomo Mitsui Trust Group's Quest Diagnostics position peaked at $126M in Q3 2021.
  • 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q1 2026, filed 30 Apr 2026.